Skip to main content

Pacific RxTracts

Publication from the Thomas J. Long School of Pharmacy at University of the Pacific.

Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.

Pacific RxTracts - August 2025

Pacific RxTracts

Articles:
- Ready. Set. Infuse: TYZAVAN Brings Vancomycin Closer to the Bedside
- ENFLONSIA: A New Era in RSV Prevention for Infants
- A Shot for Peace of Mind: Can Yeztugo Eliminate the Risk of Contracting HIV?
- Ekterly: The First Orally Administered On-Demand HAE Treatment
- Autologous Chimeric Antigen Receptor CAR T cell Immunotherapy Risk Evaluation and Mitigation Strategies Removed
- Early Tirofiban Intervention Lowers Likelihood of Disability Post-Stroke
- Obicetrapib in High Risk Patients: A New Chapter in Cholesterol Management
- Lorundrostat for Uncontrolled Hypertension: Phase 3 Clinical Trial
- The Potential of Cagrilintide/Semaglutide (CagriSema) in Weight Management
- The Unfortunate Link Between GLP-1 RAs and Neovascular Macular Degeneration
- Efsitora: A New Approach to Insulin for Type Two Diabetics
- Maintaining Potassium Homeostasis: Potential Hidden Perk of SGLT2is
- Upadacitinib: A Promising Advance in Giant-Cell Arteritis Management
- FDA’s Commissioner’s National Priority Voucher: A New Approach to Strategic Drug Development
- Potential Liver Indication for SGLT2 Inhibitors
- Unexpected Protection: How the Meningococcal Vaccine May Prevent Gonorrhea
- Beyond Monoamines: Exploring KV7 Channel Modulator Azetukalner in MDD
- Limertinib: A Promising First-Line Treatment for Non-Small Cell Lung Cancer
- Camizestrant Outperforms Aromatase Inhibitors in ESR1-Mutated ER+/HER2- Advanced Breast Cancer: A Phase 3 SERENA-6 Study
Pacific RxTracts - July 2025

Pacific RxTracts

Articles:
- First Blood Test Approved For the Diagnosis of Alzheimer’s Disease
- Rare Withdrawal Reaction Prompts Label Update for Common Antihistamines
- FDA Approves SUSVIMO: Shifting Diabetic Retinopathy Treatment from Monthly Injections to Continuous Therapy
- Battle Against Resistant Hypertension
- Two Is Better than One: Obicetrapib and Ezetimibe, a Novel Combination Pill for High Cholesterol
- Histo-blood Group ABO System Transferase and Venous Thromboembolism Risk
- GLP-1 Agonists and Thiazolidinedione Combination Therapy in Type 2 Diabetes
- Dual Pathway Targeting in Type 2 Diabetes: Exploring the Synergy of GLP1- RAs and SGLT2-inhibitors
- Two Vaccines, One Shot: Combined Immunizations Against COVID-19 and Influenza
- Mirikizumab: A New Frontier in Ulcerative Colitis Treatment
- Tocilizumab: A Better Way to Manage Rheumatoid Arthritis
- Oveporexton: A Novel Treatment Option for Narcolepsy Type I
- The Long-Term Effects of Ketamine on Treatment- Resistant Depression
- The First Targeted Therapy for a Rare Ovarian Cancer
- Vimseltinib Gains FDA Approval for Tenosynovial Giant Cell Tumour (TGCT)
- Hot Flashes No More
- Remote Clinical Pharmacists Drive Down Cancer Care Costs in Value-Based Model
- Camizestrant Takes Victory Lap After Phase 3 Trials
Pacific RxTracts - June 2025

Pacific RxTracts

Articles:
- Atzumi Receives FDA Approval as First Nasal Powder DHE for Migraine Treatment
- IMAAVY: First and Only FDA-approved Neonatal Fc Receptor Inhibitor for gMG
- New Prophylactic Treatment Approved for Hemophilia A or B, With or Without Factor Inhibitors
- Cytisinicline: The Next Smoking Cessation Aid
- FDA Approves Dupilumab for the Management of Chronic Spontaneous Urticaria
- Study Shows Promise in Combining Behavioral Treatment with Phentermine
- Metformin for Osteoarthritis
- A New Direction in Atopic Dermatitis Treatment
- Orforglipron: A Potential Oral Alternative to Injectable GLP-1 Agonists
- Beyond GLP-1s: MariTide’s Dual Mechanism in Weight Loss Therapy
- Atrasentan Gains FDA Approval to Combat Proteinuria in Primary IgA Nephropathy
- Fluoroquinolones and Increased Risk of Suicide?
- Baloxavir Offers a Promising New Indication in Reducing Influenza Transmission
- First of its Kind Antibiotic Shows Promise in Treating Uncomplicated Gonorrhea
- Tavapadon: A Promising New Therapy for Parkinson’s Disease
- Possible Dementia Protective Method by Herpes Zoster Vaccine
- From Risk to Resolution: Mitigating Drug Interactions in Cancer Treatment
- Combination Therapy In HER-2 Positive Cancer Treatment
Pacific RxTracts - April 2025

Pacific RxTracts

Articles:
- FDA Approves Miudella: First New Hormone-Free IUD in Over 40 Years
- First Treatment for Cerebrotendinous Xanthomatosis Approved
- Presepsin: A New Biomarker for Assessing Cardiovascular Disease
- New Insights into Severe NOWS Prediction
- Myasthenia Gravis: Nipocalimab, a Potential Add-on Therapy
- ARF/ARDS Concern with Trimethoprim-Sulfamethoxazole in Youth
- Hormone Replacement Therapy: Beneficial for Managing Menopausal Symptoms Long-Term?
- Esketamine Shows Promise in Preventing Postpartum Depression After Cesarean Delivery
- From One Week to One Hour: FDA Approves Label Changes for Sublocade Rapid Induction in Patients with Moderate to Severe Opioid Use Disorder
- Repurposing Semaglutide: A Novel Approach to Alcohol Use Disorder
- Treating Neuropathic Pain: Pregabalin vs. Gabapentin
- Trastuzumab Rezetecan in HER2-Mutant NSCLC: Promising Phase 2 Trial Results
- FDA Approval for Symptomatic Tenosynovial Giant Cell Tumor
- Protecting HIV Patients with Alternative HepB Vaccines
- FDA Approval of New Meningococcal Vaccination Has Greater Serogroup Coverage
Pacific RxTracts - March 2025

Pacific RxTracts

Articles
- Naloxone Extended-Release System Discovered at the University of the Pacific
- FDA Approval for Unresectable/ Metastatic Breast Cancer
- Journavx (Suzetrigine): A New Era in Pain Management
- New Treatment Approved for Congenital Adrenal Hyperplasia
- Optimal DAPT Strategy? A Promising Approach for Post-PCI Care
- Benefit of SGLT2 Inhibitors in Preventing Contrast-Induced Kidney Injury
- Dark Chocolate and Type 2 Diabetes: A Sweet Connection?
- Confirming Palbociclib’s Safety in Liver Impaired Patients
- Aztreonam-avibactam, a Promising Therapeutic for Gram-Negative Bacterial Infections
- The Future is Now: LBP-EC01, a Genetically Enhanced Bacteriophage for UTIs
- The Safety and Efficacy Profiles of Short-Term Duration Oral Regimens for Rifampin-Resistant TB
- A New Boxed Warning for Glatiramer Acetate
- Clozapine: From Last Resort to Second-Line Therapy?
- Esketamine (Spravato CIII) Receives FDA Approval as First Monotherapy Treatment for Treatment-Resistant Depression
- Evaluation of the Impacts of Cannabis Use on Brain Function
Pacific RxTracts - February 2025

Pacific RxTracts

Articles:
- Revolutionizing Hypertension Screening: AI-Enhanced ECG as a Proactive Healthcare Tool
- Breaking News:
  - New Indication for Zepbound
  - FDA Approves Injectable Nivolumab: A New Era for Opdivo in Cancer Care
  - Stromal Stem Cells for Steroid-Refractory Acute Graft-vs-Host Disease
- Cardiology:
  - Beta Blocker vs. Verapamil Therapy for Hypertrophic Cardiomyopathy
- General News:
  - Prolactin-Increasing Antipsychotics Increase the Odds of Breast Cancer
  - Hope for a Cytomegalovirus Vaccine: mRNA-1647
  - Targeting IL-13: Innovations in the Treatment of Atopic Dermatitis
  - Beyond Opioids: Multimodal Pain Management in Colorectal Surgery
  - A Nanomaterial Dosage Form for Mupirocin
  - Guselkumab, a potential drug for Ulcerative colitis
- Neuropsychiatry:
  - Dextromethorphan for Depression: More For Just a Cold
  - Breakthrough in PTSD Treatment: Brexpiprazole + Sertraline Combination Outperforms SSRI Monotherapy
  - A New Way to Treat Obsessive Compulsive and Related Disorders
  - Sovateltide: A Novel Drug for Acute Cerebral Ischemic Stroke Treatment
Pacific RxTracts - December 2024

Pacific RxTracts

Articles
- Attruby: A Promising Treatment for Transthyretin Amyloid Cardiomyopathy
- Triple Threat: GMRx2, An Emerging Low-Dose Triple Pill For Hypertension
- New Treatment for Hemophilia A or B
- Breaking the Placebo Barrier: FDA Review Challenges Effectiveness of Popular Decongestant
- Exploring Bempedoic Acid: Potential Benefits for Statin-Intolerant Patients and Liver Health
- The Flu Vaccine: Meeting You Where You Are
- Unique Application of Statins for Radiotherapy-Induced Cardiotoxicity
- One Shot, Two Solutions: How Semaglutide Combats Obesity and Knee Osteoarthritis
Pacific RxTracts - November 2024

Pacific RxTracts

Articles:
- Semaglutide: Hope for Alzheimer's Prevention
- A New Potential Indication for Tirzepatide
- New Drug Target for Treating Schizophrenia
- The Prevent Calculator: Does America Have A Statin Problem?
- Weighing the Risks vs. Benefits of Liraglutide for Children
- CD19-CAR T-Cell Therapy: Revolutionizing Autoimmune Disease Treatment
- Conceived with Technology, Born with Risks: ART Babies and Heart Defects
- Machine Learning and Neural Networks: The Future of Clinical Pharmacy?. .
Pacific RxTracts - October 2024

Pacific RxTracts

Articles
1. First Nasal Spray for Anaphylaxis Approved
2. Statins: The Unexpected Therapeutic Benefits You Didn’t Know About
3. Is COVID Driving Us Mad? The Mental Toll on the Unvaccinated vs. Vaccinated
4. Acetaminophen’s Effects on Positive Empathy
5. Semaglutide: More Than Meets The Eye
6. RSV: Complications and New Therapies
7. Contribution of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors to the Risk of Fractures
Pacific Rx Tracts: October 2009

Aarondeep Basrai, Melissa Fung, Lauren Hill, and Sheena Hokutan

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: June 2008

Nadia Aslam, Caitlin M. Downer, Phu Dinh, and Ashli N. Hickman

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: January/February 2005

Samira Arbabian, Ryan Do, Jonathan T. Dong, and Kenneth Kwan

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: July 2004

Blake M. Cunnington, Claudia Flores, Hau Z. Ho, and Naoko Horie

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: June 2004

Andrea Hong, San Hua, Carolyn A. Lee, and Regina Lum

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: October/November 2003

Jorge Abaunza, Ziba Ansari, Lily Huang, and Harlan Husted

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: November/December 2002

Jorge Abaunza, Genevieve Abdel Malik, Alex Chan, and Jinni Chow

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: August/September 2002

Vinny Faustino, Marian Hakim, Lisa Lebowitz, and Brian Pak

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: April/May 1993

Stacey Fung, Adam Kaye, Douglas Kennett, and Edith Lee

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: January/February 2002

Tracey Allen, Anietie Chizea, Natasha Hermis, and Michael Foster Holman

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: May/June 2001

Tracey Allen, Katie Bredeman, Anietie Chizea, and Amy Chuang

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: March 1998

Susan Allen, Jason Bandy, Shannan Beall, and Kristin Bergthold

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: May/June 1994

Princeton Chang, Barrie Cheung, Andrea Hall, and Ruth Hall

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: June/July 1993

Stacey Fung, Adam Kaye, Douglas Kennett, and Edith Lee

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: April/May 1993

Stacey Fung, Adam Kaye, Douglas Kennett, and Edith Lee

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.
Pacific Rx Tracts: January/February 1993

Lori Chang, Stacey Fung, John Jeleti, and Adam Kaye

Newsletter published by students of UOP's Thomas J. Long School of Pharmacy and Health Sciences, containing articles on medical studies, drug trials, and other industry-related topics.